WorldHeart LVAD Destination Therapy In Line At FDA Behind Thoratec
This article was originally published in The Gray Sheet
Executive Summary
WorldHeart will submit a PMA supplement in the third quarter seeking a destination therapy indication for its Novacor left-ventricular assist device